874
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Next-generation sequencing of formalin-fixed, paraffin-embedded tumor biopsies: navigating the perils of old and new technology to advance cancer diagnosis

Pages 769-772 | Published online: 09 Jan 2014

References

  • Blum F. Der formaldehyde als hartungsmittel. Z wiss Mikr 10, 314 (1893).
  • Hewitt SM, Lewis FA, Cao Y et al. Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue. Arch. Pathol. Lab. Med. 132(12), 1929–1935 (2008).
  • Staff S, Kujala P, Karhu R et al. Preservation of nucleic acids and tissue morphology in paraffin-embedded clinical samples: comparison of five molecular fixatives. J. Clin. Pathol. 66(9), 807–810 (2013).
  • Freidin MB, Bhudia N, Lim E, Nicholson AG, Cookson WO, Moffatt MF. Impact of collection and storage of lung tumor tissue on whole genome expression profiling. J. Mol. Diagn. 14(2), 140–148 (2012).
  • Lander ES. Initial impact of the sequencing of the human genome. Nature 470(7333), 187–197 (2011).
  • Wall DP, Tonellato PJ. The future of genomics in pathology. F1000 Med. Rep. 4, 14 (2012).
  • Diamandis M, White NM, Yousef GM. Personalized medicine: marking a new epoch in cancer patient management. Mol. Cancer Res. 8(9), 1175–1187 (2010).
  • Bozic I, Reiter JG, Allen B et al. Evolutionary dynamics of cancer in response to targeted combination therapy. eLife 2, e00747 (2013).
  • Didelot A, Kotsopoulos SK, Lupo A et al. Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples. Clin. Chem. 59(5), 815–823 (2013).
  • Sah S, Chen L, Houghton J et al. Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies. Genome Med. 5(77) (2013).
  • DePristo MA, Banks E, Poplin R et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43(5), 491–498 (2011).
  • Cibulskis K, Lawrence MS, Carter SL et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31(3), 213–219 (2013).
  • Hadd AG, Houghton J, Choudhary A et al. Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens. J. Mol. Diagn. 15(2), 234–247 (2013).
  • Singh RR, Patel KP, Routbort MJ et al. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. J. Mol. Diagn. 15(5), 607–622 (2013).
  • Spencer DH, Sehn JK, Abel HJ, Watson MA, Pfeifer JD, Duncavage EJ. Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens. J. Mol. Diagn. 15(5), 623–633 (2013).
  • Plon SE, Eccles DM, Easton D et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum. Mutat. 29(11), 1282–1291 (2008).
  • Gargis AS, Kalman L, Berry MW et al. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat. Biotechnol. 30(11), 1033–1036 (2012).
  • van El CG, Cornel MC, Borry P et al. Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur. J. Human Gene. 21( Suppl. 1), S1–S5 (2013).
  • Weiss MM, Van der Zwaag B, Jongbloed JD et al. Best practice guidelines for the use of next-generation sequencing applications in genome diagnostics: A national collaborative study of dutch genome diagnostic laboratories. Hum. Mutat. (2013).
  • Rehm HL, Bale SJ, Bayrak-Toydemir P et al. ACMG clinical laboratory standards for next-generation sequencing. Genet. Med. 15(9), 733–747 (2013).
  • Schrijver I, Aziz N, Farkas DH et al. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. J. Mol. Diagn. 14(6), 525–540 (2012).
  • Forshew T, Murtaza M, Parkinson C et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4(136), 136ra1681 (2012).
  • Yost SE, Smith EN, Schwab RB et al. Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens. Nucleic Acids Res. 40(14), e107 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.